Program Committee

Program Committee Members

Christine Bradway, PhD, CRNP, 2022 AGS Annual Scientific Meeting Chair
Nicole J. Brandt, PharmD, MBA, BCGP, BCPP, FASCP  
Anna Chang, MD
Lenise Cummings-Vaughan, MD
Kathryn M. Daniel, PhD, RN, ANP-BC, GNP-BC, AGSF
Ellen Flaherty, PhD, APRN, BC
Michael Harper, MD, AGS President-elect
Peter Hollmann, MD, AGS President
Theodore Johnson, MD
Amy Kelley, MD
Annie Medina-Walpole, MD, PEEC Chair
Aanand Naik, MD
James T. Pacala, MD, MS
Joseph Shega, MD
Liron Sinvani, MD
Caroline Vitale, MD

Disclosure of relationships with ineligible companies

As an ACCME accredited provider of Continuing Medical Education, the American Geriatrics Society must ensure balance, independence, objectivity and scientific rigor in all of our educational activities. We have implemented a process wherein everyone who is in a position to control the content of an education activity has disclosed to us all financial relationships with any ineligible company within the prior 24 months. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.  AGS then reviews the disclosure information to determine which financial relationships are relevant and mitigates relevant financial relationships with ineligible companies to prevent commercial bias in the content.  

Relevant financial relationships with ineligible companies for members of the Program Committee have been mitigated through peer review of planning decisions by persons without relevant financial relationships and recusal from any aspect of planning and content related to the financial relationship.

Committee Member Disclosure
Christine Bradway, PhD, CRNP No financial relationships with ineligible companies.
Nicole J. Brandt, PharmD, MBA, BCGP, BCPP, FASCP No financial relationships with ineligible companies.
Anna Chang, MD No financial relationships with ineligible companies.
Lenise Cummings-Vaughan, MD No financial relationships with ineligible companies.
Kathryn M. Daniel, PhD, RN, ANP-BC, GNP-BC, AGSF No financial relationships with ineligible companies.
Ellen Flaherty, PhD, APRN, BC No financial relationships with ineligible companies.
Michael Harper, MD No financial relationships with ineligible companies.
Peter Hollmann, MD CVS Caremark (PBM): Reviewer of Drug Utilization Review Criteria per RI state regs
Theodore Johnson, MD Astellas: Consultant
Medtronic: Research support- at home monitoring system
Dexcom: Research support- CGM in long-term care
Eisai: Consultancy on primary care treatment planning for AlzDz
 
Amy Kelley, MD No financial relationships with ineligible companies.
Annie Medina-Walpole, MD No financial relationships with ineligible companies.
Aanand Naik, MD No financial relationships with ineligible companies.
James T. Pacala, MD, MS No financial relationships with ineligible companies.
Joseph Shega, MD No financial relationships with ineligible companies.
Liron Sinvani, MD No financial relationships with ineligible companies.
Caroline Vitale, MD No financial relationships with ineligible companies.